98 related articles for article (PubMed ID: 18633939)
21. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor.
Kinomoto M; Yokoyama M; Sato H; Kojima A; Kurata T; Ikuta K; Sata T; Tokunaga K
J Virol; 2005 May; 79(10):5996-6004. PubMed ID: 15857986
[TBL] [Abstract][Full Text] [Related]
22. X-ray crystallographic study of an HIV-1 fusion inhibitor with the gp41 S138A substitution.
Watabe T; Terakawa Y; Watanabe K; Ohno H; Nakano H; Nakatsu T; Kato H; Izumi K; Kodama E; Matsuoka M; Kitaura K; Oishi S; Fujii N
J Mol Biol; 2009 Sep; 392(3):657-65. PubMed ID: 19616557
[TBL] [Abstract][Full Text] [Related]
23. Development of a FRET assay for monitoring of HIV gp41 core disruption.
Xu Y; Hixon MS; Dawson PE; Janda KD
J Org Chem; 2007 Aug; 72(18):6700-7. PubMed ID: 17685571
[TBL] [Abstract][Full Text] [Related]
24. Oligomerization of the hydrophobic heptad repeat of gp41.
Bernstein HB; Tucker SP; Kar SR; McPherson SA; McPherson DT; Dubay JW; Lebowitz J; Compans RW; Hunter E
J Virol; 1995 May; 69(5):2745-50. PubMed ID: 7707497
[TBL] [Abstract][Full Text] [Related]
25. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
[TBL] [Abstract][Full Text] [Related]
26. 13C-13C and (15)N-(13)C correlation spectroscopy of membrane-associated and uniformly labeled human immunodeficiency virus and influenza fusion peptides: amino acid-type assignments and evidence for multiple conformations.
Bodner ML; Gabrys CM; Struppe JO; Weliky DP
J Chem Phys; 2008 Feb; 128(5):052319. PubMed ID: 18266436
[TBL] [Abstract][Full Text] [Related]
27. [Studies on the spectral characteristics of efficient HIV-1 fusion inhibitor C22].
Shi J; He JJ; Wang SL; Sun XY; Chen QY
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1862-5. PubMed ID: 18975820
[TBL] [Abstract][Full Text] [Related]
28. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM
FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423
[TBL] [Abstract][Full Text] [Related]
29. Conditional trimerization and lytic activity of HIV-1 gp41 variants containing the membrane-associated segments.
Dai Z; Tao Y; Liu N; Brenowitz MD; Girvin ME; Lai JR
Biochemistry; 2015 Mar; 54(8):1589-99. PubMed ID: 25658332
[TBL] [Abstract][Full Text] [Related]
30. Stability of gp41 hairpin and helix bundle assembly probed by combined stacking and circular dichroic approaches.
Chang CC; Cheng SF; Lin CH; Chen SS; Chang DK
J Struct Biol; 2011 Sep; 175(3):406-14. PubMed ID: 21722736
[TBL] [Abstract][Full Text] [Related]
31. Membrane binding properties of EBV gp110 C-terminal domain; evidences for structural transition in the membrane environment.
Park SJ; Seo MD; Lee SK; Lee BJ
Virology; 2008 Sep; 379(2):181-90. PubMed ID: 18687450
[TBL] [Abstract][Full Text] [Related]
32. The leucine zipper motif of the envelope glycoprotein ectodomain of human immunodeficiency virus type 1 contains conformationally flexible regions as revealed by NMR and circular dichroism studies in different media.
Chang DK; Trivedi VD; Cheng SF; Francis S
J Pept Res; 2001 Mar; 57(3):234-9. PubMed ID: 11298925
[TBL] [Abstract][Full Text] [Related]
33. Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1. Implications on viral fusion mechanism.
Chang DK; Cheng SF; Trivedi VD
J Biol Chem; 1999 Feb; 274(9):5299-309. PubMed ID: 10026137
[TBL] [Abstract][Full Text] [Related]
34. Insights into the Conformation of the Membrane Proximal Regions Critical to the Trimerization of the HIV-1 gp41 Ectodomain Bound to Dodecyl Phosphocholine Micelles.
Louis JM; Baber JL; Ghirlando R; Aniana A; Bax A; Roche J
PLoS One; 2016; 11(8):e0160597. PubMed ID: 27513582
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.
Lu M; Stoller MO; Wang S; Liu J; Fagan MB; Nunberg JH
J Virol; 2001 Nov; 75(22):11146-56. PubMed ID: 11602754
[TBL] [Abstract][Full Text] [Related]
36. Monomer-trimer equilibrium of the ectodomain of SIV gp41: insight into the mechanism of peptide inhibition of HIV infection.
Caffrey M; Kaufman J; Stahl S; Wingfield P; Gronenborn AM; Clore GM
Protein Sci; 1999 Sep; 8(9):1904-7. PubMed ID: 10493592
[TBL] [Abstract][Full Text] [Related]
37. Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery.
Walsh JD; Chu S; Zhang SQ; Gochin M
Protein Eng Des Sel; 2015 Apr; 28(4):107-16. PubMed ID: 25792539
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes.
Moreno MR; Guillén J; Pérez-Berna AJ; Amorós D; Gómez AI; Bernabeu A; Villalaín J
Biochemistry; 2007 Sep; 46(37):10572-84. PubMed ID: 17711304
[TBL] [Abstract][Full Text] [Related]
40. Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.
Boutonnet N; Janssens W; Boutton C; Verschelde JL; Heyndrickx L; Beirnaert E; van der Groen G; Lasters I
J Virol; 2002 Aug; 76(15):7595-606. PubMed ID: 12097573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]